BCAP31 and breast carcinoma: Our study reveals that the knockdown of BAP31 effectively inhibits tumor growth and stemness in both in vitro and in vivo settings, suggesting that targeting BAP31 may serve as a promising therapeutic approach for the treatment of breast cancer.